zintick

KALA BIO KALA

KALA BIO, Inc. · Nasdaq · Pharmaceutical Preparations

$0.16-5.85%close on Nov. 12, 2026 · volume 361K · Yahoo Finance

Price, last 58 sessions

$0.20$0.40$0.60$0.80Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 12, 2026 · high $0.82 · low $0.15 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 8 →
  • 8-KNov. 12, 2026, 4:25 p.m. ETView on SEC.govOur explainer

    Material modification of security holders' rights · Amendments to articles or bylaws; fiscal year change · Other events · Financial statements and exhibits

    AI summary, unreviewedKALA BIO Announces 1-for-30 Reverse Stock Split Effective November 13, 2026, Trading Split-Adjusted from November 16

  • 8-KNov. 9, 2026, 9:01 a.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedKALA BIO Reports Preliminary Q3 2026 Net Loss of Approximately $0.8 Million, Down From $7.6 Million a Year Earlier

  • 8-KNov. 3, 2026, 4:11 p.m. ETView on SEC.gov

    Submission of matters to a vote of security holders

    AI summary, unreviewedKALA BIO shareholders approve reverse stock split authority of 1-for-2 to 1-for-300 at annual meeting

  • SCHEDULE 13GOct. 19, 2026, 9:09 a.m. ETView on SEC.gov
  • 8-KSept. 10, 2026, 5:24 p.m. ETView on SEC.gov

    Entry into a material definitive agreement · Financial statements and exhibits

  • 8-KSept. 9, 2026, 5:06 p.m. ETView on SEC.gov

    Shareholder director nominations · Other events

  • 8-KAug. 28, 2026, 6:45 a.m. ETView on SEC.gov

    Delisting notice / failure to meet listing standard

  • 10-QAug. 19, 2026, 4:16 p.m. ETView on SEC.gov